Real-World Analysis of SGLT2 Inhibitors to Prevent Cardiovascular and Kidney Outcomes in Patients with CKD: A Population-Based Cohort Study

Authors
Category Primary study
JournalJournal of the American Society of Nephrology
Year 2024
This article has no abstract
Epistemonikos ID: 922a4120987c5c8836c168eb679c55fbe0a0a19e
First added on: Feb 19, 2025